DEBATE: Should recently approved antiepileptic drugs be used early in the treatment of epilepsy? The answer is YES. SEE also CON POSITION and COMMENTARY
Epilepsy: Less Conventional Treatments
October 29, 2010
The copyright for all illustrations and pictures has been heeded by all authors to the best of their knowledge. If you feel your copyright has been infringed in any way or if you have any questions, do contact us by clicking on this link, please.
|Congress:||The 4th World Congress on Controversies in Neurology (CONy)|
My task is to convince you that recently approved AEDs should be used early in the treatment of epilepsy if it likely to be beneficial for the individual patient. Recently approved AEDs are arbitrarily defined here as add-on AEDs such as eslicarbazepine-acetate, lacosamide and rufinamide that have been approved following the introduction of levetiracetam as add-on drug. For new onset focal epilepsy levetiracetam is considered to be a recently approved agent.
|Category:||Neurology; Epilepsy; treatment; hormonal therapy; antiepileptic drugs;|